Trump's Executive Order on cannabis rescheduling expected on Monday: CNBC
Source: SeekingAlpha
2025-12-12 11:25:00 ET
More on cannabis ETFs and Tilray
- MSOS: Focused Exposure To U.S. Cannabis Stocks
- Tilray Brands Is No Longer A Strong Sell
- Tilray: Still Not Worth Buying
- Pot stocks rise on Trump's push to reclassify marijuana
- Trump could seek Executive Order to reclassify marijuana - report
Read the full article on Seeking Alpha
For further details see:
Trump’s Executive Order on cannabis rescheduling expected on Monday: CNBC
AdvisorShares Pure US Cannabis ETF
NASDAQ: MSOS
MSOS Trading
-4.1% G/L:
$4.79 Last:
2,282,044 Volume:
$5.03 Open:
MSOS Latest News
April 24, 2026 11:41:23 am
Trump Just Eased Federal Marijuana Laws. Is there an Investment Case for Cannabis ETFs Right Now?
April 23, 2026 09:24:00 am
AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling
February 23, 2026 12:29:41 pm
Quantum Computing Inc. Positions Itself Between Quantum Hardware and Enterprise Adoption as Anson Funds Exits
February 17, 2026 08:15:00 pm
If Pot Stocks Rebound in 2026, These Are the 3 Best Cannabis Companies to Own
